Morphine sulfate and Reopro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Morphine sulfate (morphine sulfate) and Reopro (abciximab). Common drug interactions include osteonecrosis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Morphine sulfate and Reopro. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Morphine sulfate?

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 87,261 Morphine sulfate users. Check the latest studies of Morphine sulfate.

What is Reopro?

Reopro has active ingredients of abciximab. eHealthMe is studying from 4,782 Reopro users. Check the latest studies of Reopro.



On Jul, 15, 2026

19 people who take Morphine sulfate and Reopro together, and have interactions are studied.

Morphine sulfate and Reopro drug interactions.

What are the common drug interactions of Morphine Sulfate and Reopro, by gender? *:

female:

  1. Osteonecrosis (death of bone)
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Acute myocardial infarction (acute heart attack)
  4. Anaemia (lack of blood)
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Arteriovenous fistula
  7. Cardiac arrest
  8. Cardiac failure congestive
  9. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

male:

  1. Pneumonia
  2. Haemorrhage (bleeding)
  3. Abdominal pain
  4. Activated partial thromboplastin time prolonged
  5. Anaemia (lack of blood)
  6. Blood pressure decreased
  7. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  8. Chest pain
  9. Coma (state of unconsciousness lasting more than six hours)
  10. Coronary artery reocclusion (blockage after treatment of coronary artery)

What are the common drug interactions of Morphine Sulfate and Reopro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Blood pressure decreased
  4. Leukocytosis (increased white blood cells)
  5. Pancreatitis (inflammation of pancreas)
  6. Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Thrombocytopenia (decrease of platelets in blood)

50-59:

  1. Haemorrhage (bleeding)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

  1. Autoimmune thrombocytopenia (isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia)
  2. Osteonecrosis (death of bone)
  3. Cardiac arrest
  4. Cardiac failure congestive
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Haematocrit decreased
  9. Haematoma (collection of blood outside the blood vessels)
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 4 people, 21.05%
  2. Nausea (feeling of having an urge to vomit): 4 people, 21.05%
  3. High Blood Pressure: 3 people, 15.79%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 15.79%
  5. Sedation: 2 people, 10.53%
  6. Quit Smoking: 2 people, 10.53%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
  8. High Density Lipoprotein Decreased: 2 people, 10.53%
  9. Heart Attack: 2 people, 10.53%
  10. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine sulfate and Reopro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Morphine sulfate and Reopro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Morphine sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reopro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reopro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and abciximab (the active ingredients of Morphine sulfate and Reopro, respectively), and Morphine sulfate and Reopro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: